June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Blockade of Epithelial Membrane Protein-2 Decreases Corneal Neovascularization in a Burn Model
Ann M Chan; Meagan Kiyohara; Christen M Dillard; Daniel Diaz-Aguilar; Saad Shah; Teevit Dunnsiri; Madhuri Wadehra; Lynn K Gordon
Author Affiliations & Notes
  • Ann M Chan
    Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA
  • Meagan Kiyohara
    Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA
  • Christen M Dillard
    Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA
  • Daniel Diaz-Aguilar
    Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA
  • Saad Shah
    Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA
  • Teevit Dunnsiri
    Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA
  • Madhuri Wadehra
    Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA
  • Lynn K Gordon
    Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA
  • Footnotes
    Commercial Relationships Ann Chan, Paganini BioPharma, Inc. (E); Meagan Kiyohara, None; Christen Dillard, None; Daniel Diaz-Aguilar, None; Saad Shah, None; Teevit Dunnsiri, None; Madhuri Wadehra, Paganini BioPharma, Inc. (C); Lynn Gordon, Paganini BioPharma, Inc. (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5651. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Blockade of Epithelial Membrane Protein-2 Decreases Corneal Neovascularization in a Burn Model
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Ann M Chan, Meagan Kiyohara, Christen M Dillard, Daniel Diaz-Aguilar, Saad Shah, Teevit Dunnsiri, Madhuri Wadehra, Lynn K Gordon; Blockade of Epithelial Membrane Protein-2 Decreases Corneal Neovascularization in a Burn Model. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5651. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: Corneal neovascularization (NV) can result from infection, prolonged use of contact lens, direct or chemical trauma, or immunologic disease. Vision loss may result from corneal NV. Epithelial membrane protein 2 (EMP2), a member of GAS3/PMP22 tetraspan protein family, is expressed in the corneal epithelium, and controls VEGF expression in ocular epithelial cell lines. The goal of this study is to examine the relationship between EMP2 and neovascularization of the cornea in a burn model.

Methods: Human corneal limbal epithelial (HCLE) cell line was exposed to nutrient deprivation, and used to examine the expression of pro-angiogenic proteins. Small hairpin-RNA was used to knockdown EMP2 expression in HCLE cells. Corneal NV was induced in 6-8 week old female Balb/c mice using a NaOH burn method. Mice were treated with a recombinant anti-EMP2 or control antibody via subconjunctival injection immediately after the corneal burn. Animals were clinically evaluated to determine the extent of NV. Seven days post treatment, the eyes were enucleated and immunohistochemical studies were performed to identify the vasculature using antibodies against CD34 and VEGF.

Results: In vitro analysis on HCLE cells via Western blot showed a decrease in phospho-STAT3, upon EMP2 knockdown (p< 0.01). Subconjunctival injections of anti-EMP2 antibody, but not the control antibody, significantly decreased EMP2 expression in the cornea epithelium at day 7. Clinically, less corneal NV was observed in the eyes that received the subconjunctival injection of anti-EMP2 antibody than saline controls or with a control antibody (p< 0.03). In the anti- EMP2 treated animals, as compared to the controls, histological measurement of the central region of the cornea showed reduced thickness, and anti-CD34 and VEGF immunohistochemistry indicated a decrease in expression.

Conclusions: Knockdown of EMP2 expression in HCLE cells decreases STAT3 phosphorylation. Subconjunctival injections of anti-EMP2 antibody reduces the corneal epithelial expression of CD34 and VEGF as well as decreases clinical evidence of corneal NV following ocular burn using NaOH. Modulation of EMP2 expression may provide a new method of preventing corneal neovascularization following injury.

The Association for Research in Vision and Ophthalmology
Copyright © 2015 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept